BRIDGING THE GAP | 2026 Regulatory Alignment for Clinical Trials in Israel and the EU
As part of our continued leadership in the healthcare & life sciences space, we’re pleased to collaborate with GCs for GCs | יועמ״שים למען יועמ״שים and the Europe – Israel Economic & Innovation Forum on an webinar exploring EU and Israeli clinical trial requirements.
With Israel’s vibrant health and biotech ecosystem and with a significant share of clinical trials involving Israeli sites being multinational, navigating compliance requirements between Israel and Europe has become a key practical hurdle for companies planning global clinical development.
BRIDGING THE GAP | 2026 Regulatory Alignment for Clinical Trials in Israel and the EU
17 February 2026 | 11:00–12:30 (Israel time)
A key part of the session will be led by Lana Tavor, Partner in our High-Tech Department and a leading expert in clinical trials and healthcare compliance, sharing the Israeli perspective and practical takeaways for managing clinical trial engagements in Israel.
For registration, click here: https://lnkd.in/dbDvtTif
More Relevant Media
FDA Guidance – Clinical Trial Diversity Action Plans – Client Update – January 2025
AI in Clinical Trials, Moving from Pilot to Scale and the Trust Gap That Still Holds It Back
NeuroDerm Ltd achieved highly positive results from their pivotal clinical trial
The game-changing trend of using unmanned aerial vehicles for the delivery of healthcare products